Ling C - Search Results

1

Low Expression of SCN4B Predicts Poor Prognosis in Non-Small Cell Lung Cancer.

Li X, Chen W, Jiang S, Zhang L, Huang H, Ji Y, Ni Q, Ling C. Li X, et al. Among authors: ling c. Curr Cancer Drug Targets. 2024 Jul 2. doi: 10.2174/0115680096293516240607071915. Online ahead of print. Curr Cancer Drug Targets. 2024. PMID: 38956906

2

A deuterated analog of dasatinib disrupts cell cycle progression and displays anti-non-small cell lung cancer activity in vitro and in vivo.

Ling C, Chen G, Chen G, Zhang Z, Cao B, Han K, Yin J, Chu A, Zhao Y, Mao X. Ling C, et al. Int J Cancer. 2012 Nov 15;131(10):2411-9. doi: 10.1002/ijc.27504. Epub 2012 Mar 28. Int J Cancer. 2012. PMID: 22362357

3

[Expression of endoglin in human non-small cell lung cancer and its clinical significance].

Li M, Lu S, Liu X, Zhao J, Zhang H, Ling C. Li M, et al. Among authors: ling c. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013 Jun;29(6):581-4. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013. PMID: 23746240 Chinese.

4

MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.

Ling C, Wang X, Zhu J, Tang H, Du W, Zeng Y, Sun L, Huang JA, Liu Z. Ling C, et al. Cancer Med. 2019 Jul;8(7):3520-3531. doi: 10.1002/cam4.2220. Epub 2019 May 10. Cancer Med. 2019. PMID: 31074594 Free PMC article.

5

Analysis of the long non-coding RNA LINC01614 in non-small cell lung cancer.

Sun Y, Ling C. Sun Y, et al. Among authors: ling c. Medicine (Baltimore). 2019 Jul;98(30):e16437. doi: 10.1097/MD.0000000000016437. Medicine (Baltimore). 2019. PMID: 31348244 Free PMC article.

6

MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells.

Liu Z, Zhang W, Zhang B, Chen S, Ling C. Liu Z, et al. Among authors: ling c. Genet Test Mol Biomarkers. 2022 Jul-Aug;26(7-8):351-359. doi: 10.1089/gtmb.2021.0158. Genet Test Mol Biomarkers. 2022. PMID: 36027039

7

Th1high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC.

Huang J, Shen F, Huang H, Ling C, Zhang G. Huang J, et al. Among authors: ling c. Oncotarget. 2017 Feb 21;8(8):13116-13125. doi: 10.18632/oncotarget.14471. Oncotarget. 2017. PMID: 28061450 Free PMC article.

8

RNPC1 inhibits non-small cell lung cancer progression via regulating miR-181a/CASC2 axis.

Yang L, Zhang Y, Ling C, Heng W. Yang L, et al. Among authors: ling c. Biotechnol Lett. 2018 Mar;40(3):543-550. doi: 10.1007/s10529-017-2504-1. Epub 2017 Dec 29. Biotechnol Lett. 2018. PMID: 29288351

9

PIASy antagonizes Ras-driven NSCLC survival by promoting GATA2 SUMOylation.

Chen B, Luo J, Zhou Y, Xin X, Cai R, Ling C. Chen B, et al. Among authors: ling c. J Cancer. 2018 Apr 18;9(9):1689-1697. doi: 10.7150/jca.24137. eCollection 2018. J Cancer. 2018. PMID: 29760808 Free PMC article.

10

Profiles and Bioinformatics Analysis of Differentially Expressed Circrnas in Taxol-Resistant Non-Small Cell Lung Cancer Cells.

Xu N, Chen S, Liu Y, Li W, Liu Z, Bian X, Ling C, Jiang M. Xu N, et al. Among authors: ling c. Cell Physiol Biochem. 2018;48(5):2046-2060. doi: 10.1159/000492543. Epub 2018 Aug 10. Cell Physiol Biochem. 2018. PMID: 30099455 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,200 results

Search Page

Filters